Scott Marsh Financial’s Novo Nordisk NVO Stock Holding History

Scott Marsh Financial’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$391K	Buy	+5,659	New	+$385K	0.14%	176

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Scott Marsh Financial's NVO Position: Q2 2025 in Review

Scott Marsh Financial opened a new position in Novo Nordisk (NVO) in Q2 2025: 5,659 shares worth $391K. The stake represents 0.14% of the portfolio and ranks #176 among its holdings.

1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

Scott Marsh Financial held 5,659 shares of Novo Nordisk worth $391K as of Q2 2025.
Novo Nordisk was a new Scott Marsh Financial position in Q2 2025.
Novo Nordisk made up 0.14% of Scott Marsh Financial's portfolio in Q2 2025, its #176 holding.
1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on Scott Marsh Financial's 13F filing for Q2 2025, filed 14 Aug 2025.